Video

Regulating Personalized Therapeutics: Are There Precedents?

Source: Cytiva

In this segment of the BioProcess Online Live event Gene & RNA Therapies: Regulatory Requirements Take Shape, Drs. Nina Hunter VP, Regulatory and Science Policy at REGENXBIO and Naveed Shams, M.D., Ph.D. Chief Science Officer at ProQR Therapeutics discuss the regulatory challenges presented by personalized therapeutics and the precedents that might inform your go-forward plans.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva